| AAVS1 |
|
adeno-associated virus integration site 1
|
|
|
0.595 |
0.731 |
| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| RNASE3 |
P12724
|
ribonuclease A family member 3
|
|
|
0.490 |
0.808 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| MIRLET7G |
|
microRNA let-7g
|
|
|
0.606 |
0.769 |
| MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
| MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
| MIR145 |
|
microRNA 145
|
|
|
0.431 |
0.846 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR17 |
|
microRNA 17
|
|
|
0.459 |
0.846 |
| MIR99B |
|
microRNA 99b
|
|
|
0.633 |
0.615 |
| VN1R17P |
Q8TDU5
|
vomeronasal 1 receptor 17 pseudogene
|
|
|
0.529 |
0.923 |
| GPR166P |
|
G protein-coupled receptor 166 pseudogene
|
|
|
0.531 |
0.923 |
| LINC01672 |
|
long intergenic non-protein coding RNA 1672
|
|
|
0.462 |
0.846 |
| ERICD |
|
E2F1-regulated inhibitor of cell death
|
|
|
0.691 |
0.654 |